These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17154032)

  • 1. [A case of hyperglycemic neuropathy with possible dysfunction of axonal excitability].
    Terasawa Y; Nodera H; Satoh K; Nakane S; Izumi Y; Kaji R
    Rinsho Shinkeigaku; 2006 Aug; 46(8):540-3. PubMed ID: 17154032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Clin Neurophysiol; 2006 May; 117(5):992-9. PubMed ID: 16516547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Brain; 2006 Jun; 129(Pt 6):1585-92. PubMed ID: 16636020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV; Lin CS; Kiernan MC
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system involvement in multifocal demyelinating neuropathy with persistent conduction block.
    Péréon Y; Jardel J; Guillon B; Guihéneuc P
    Muscle Nerve; 1994 Nov; 17(11):1278-85. PubMed ID: 7935550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy associated with chronic natural killer cell lymphocytosis.
    Noguchi M; Yoshita M; Sakai K; Matsumoto Y; Arahata M; Ontachi Y; Takami A; Nakao S; Sato K; Yamada M
    J Neurol Sci; 2005 May; 232(1-2):119-22. PubMed ID: 15850593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute effects of glycemic control on axonal excitability in human diabetics.
    Kitano Y; Kuwabara S; Misawa S; Ogawara K; Kanai K; Kikkawa Y; Yagui K; Hattori T
    Ann Neurol; 2004 Oct; 56(4):462-7. PubMed ID: 15455400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of peripheral nerve demyelination: basic and clinical aspects.
    Kimura J
    Can J Neurol Sci; 1993 Nov; 20(4):263-70. PubMed ID: 8313241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic axonal-demyelinating polyradicular neuropathy associated with mycosis fungoides: a case report.
    Cardinali P; Serrao M; Rossi P; De Dominicis L; Logullo F; De Santis F; Pierelli F
    Neurol Sci; 2005 Dec; 26(5):344-8. PubMed ID: 16388370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy--a novel finding in dyskeratosis congenita.
    Ip P; Knight R; Dokal I; Manzur AY; Muntoni F
    Eur J Paediatr Neurol; 2005; 9(2):85-9. PubMed ID: 15843075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
    Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of proximal conduction velocity at distal nerve injury in carpal tunnel syndrome: demyelinating versus axonal change.
    Chang MH; Liu LH; Lee YC; Hsieh PF
    J Clin Neurophysiol; 2008 Jun; 25(3):161-6. PubMed ID: 18469728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In response to "Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies".
    Caliandro P; Stålberg E; Padua L
    Clin Neurophysiol; 2008 Jul; 119(7):1694-5. PubMed ID: 18467169
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypokalemic weakness in hyperaldosteronism: activity-dependent conduction block.
    Krishnan AV; Colebatch JG; Kiernan MC
    Neurology; 2005 Oct; 65(8):1309-12. PubMed ID: 16247066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of multiple sclerosis associated with myelin associated glycoprotein neuropathy].
    Nakane S; Furuya T; Shirabe S; Nakamura T; Yoshimura T
    Rinsho Shinkeigaku; 1998 Dec; 38(12):1042-8. PubMed ID: 10349346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
    Sawai S; Kanai K; Nakata M; Hiraga A; Misawa S; Isose S; Hattori T; Kuwabara S
    Clin Neurophysiol; 2008 May; 119(5):1097-105. PubMed ID: 18342570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute multifocal painful neuropathy with spontaneous remission.
    Satake M; Yoshimura T; Yamada T; Kira J
    Fukuoka Igaku Zasshi; 1998 Jun; 89(6):179-84. PubMed ID: 9695315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies.
    Kaji R
    Muscle Nerve; 2003 Mar; 27(3):285-96. PubMed ID: 12635114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of nerve conduction blocks in peripheral neuropathies].
    Kuntzer T
    Rev Med Suisse Romande; 1992 Jul; 112(7):611-9. PubMed ID: 1323138
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible multifocal conduction block in sarcoid neuropathy.
    Suzuki C; Tomiyama M; Baba M; Jinichi N; Ogawa M; Kurahashi K; Kamijo M
    J Peripher Nerv Syst; 2006 Mar; 11(1):93-5. PubMed ID: 16519790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.